WO2012033329A3 - Composition containing oenanthe javanica extract as an active ingredient for preventing or treating learning disabilities or memory disorders, and method for preparing same - Google Patents
Composition containing oenanthe javanica extract as an active ingredient for preventing or treating learning disabilities or memory disorders, and method for preparing same Download PDFInfo
- Publication number
- WO2012033329A3 WO2012033329A3 PCT/KR2011/006591 KR2011006591W WO2012033329A3 WO 2012033329 A3 WO2012033329 A3 WO 2012033329A3 KR 2011006591 W KR2011006591 W KR 2011006591W WO 2012033329 A3 WO2012033329 A3 WO 2012033329A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- preventing
- active ingredient
- composition containing
- preparing same
- oenanthe javanica
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Organic Chemistry (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The present invention relates to a composition containing Oenanthe javanica extract as an active ingredient for preventing or treating learning disabilities or memory disorders, and to a method for preparing same. More particularly, the present invention relates to a composition which can be used as a pharmaceutical composition or functional health food and which is prepared by extracting an active ingredient from Oenanthe javanica, which is an edible herb, wherein the active ingredient provides the function of preventing acetylcholinesterase (AChE) from being activated, or the function of preventing or treating learning disability or memory disorder.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201180043211.8A CN103153322B (en) | 2010-09-08 | 2011-09-07 | Containing oenanthe javanica extract as the learning capacity of effective ingredient or memory disorder prevention or therapeutic composition and manufacture method thereof |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2010-0087923 | 2010-09-08 | ||
KR20100087923 | 2010-09-08 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2012033329A2 WO2012033329A2 (en) | 2012-03-15 |
WO2012033329A3 true WO2012033329A3 (en) | 2012-06-28 |
Family
ID=45811067
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2011/006591 WO2012033329A2 (en) | 2010-09-08 | 2011-09-07 | Composition containing oenanthe javanica extract as an active ingredient for preventing or treating learning disabilities or memory disorders, and method for preparing same |
Country Status (3)
Country | Link |
---|---|
KR (1) | KR101280421B1 (en) |
CN (1) | CN103153322B (en) |
WO (1) | WO2012033329A2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108570058B (en) * | 2018-06-05 | 2019-06-28 | 南阳师范学院 | A kind of biphenyl type lignan compound and its method and purposes from oenanthe stolonifera extraction |
KR102296347B1 (en) * | 2019-11-27 | 2021-09-01 | 강원대학교산학협력단 | Composition for preventing the ischemic stroke disease containing natural complex extract |
KR20210147707A (en) | 2020-05-29 | 2021-12-07 | 좋은영농조합법인 | Composition for relieving and preventing hangover comprising Oenanthe javanica extracts |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20000009588A (en) * | 1998-07-27 | 2000-02-15 | 한수길 | Angiotensin i convertase inhibitor |
KR20010097307A (en) * | 2000-04-21 | 2001-11-08 | 이인수 | Dietary prevention and anti-metastatic composition for lung cancer containing Minari-extract |
KR20030085771A (en) * | 2002-05-01 | 2003-11-07 | 메디코룩스(주) | A composition for whitening containing dropwort extract |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1187076C (en) * | 2003-02-26 | 2005-02-02 | 包头市千年健药物研究开发有限公司 | Medicine for treating senile dementia and preparation method |
-
2011
- 2011-09-07 KR KR1020110090830A patent/KR101280421B1/en active IP Right Grant
- 2011-09-07 WO PCT/KR2011/006591 patent/WO2012033329A2/en active Application Filing
- 2011-09-07 CN CN201180043211.8A patent/CN103153322B/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20000009588A (en) * | 1998-07-27 | 2000-02-15 | 한수길 | Angiotensin i convertase inhibitor |
KR20010097307A (en) * | 2000-04-21 | 2001-11-08 | 이인수 | Dietary prevention and anti-metastatic composition for lung cancer containing Minari-extract |
KR20030085771A (en) * | 2002-05-01 | 2003-11-07 | 메디코룩스(주) | A composition for whitening containing dropwort extract |
Non-Patent Citations (2)
Title |
---|
HAN, Y.-Q. ET AL.: "In vivo and in vitro anti-hepatitis B virus activity of total phenolics from Oenanthe javanica", JOURNAL OF ETHNOPHARMACOLOGY, vol. 118, no. 1, June 2008 (2008-06-01), pages 148 - 153 * |
YANG, X.-B. ET AL.: "Antidiabetic effect of Oenanthe javanica flavone", ACTA PHARMACOLOGICA SINICA, vol. 21, no. 3, March 2000 (2000-03-01), pages 239 - 242 * |
Also Published As
Publication number | Publication date |
---|---|
KR20120026010A (en) | 2012-03-16 |
WO2012033329A2 (en) | 2012-03-15 |
KR101280421B1 (en) | 2013-07-01 |
CN103153322B (en) | 2015-10-07 |
CN103153322A (en) | 2013-06-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2009125964A3 (en) | Composition comprising polysaccharide extracted from panax ginseng preventing and treating liver diseases | |
WO2009012871A3 (en) | Uv filter capsule | |
WO2011090270A3 (en) | Composition containing osmotin for preventing and treating neurological disorders | |
PH12015502263A1 (en) | Composition for preventing or treating hangover | |
WO2011051633A3 (en) | Use of a punica granatum extract to fight against the whitening of the hair | |
WO2011059292A3 (en) | Aloe vera sprout concentrate or extract having superior skin cell growth promotion, antioxidant, and anti-allergy effects | |
WO2011082235A3 (en) | Methods for stimulating growth and preventing loss of human hair | |
EP3176163A4 (en) | Novel indene derivative, preparation method for same, and pharmaceutical composition, for preventing or treating retinal diseases, containing same as active ingredient | |
WO2011043631A3 (en) | Pharmaceutical composition for preventing and treating cold, containing reynoutria elliptica extract, fraction thereof or stilbene-based compound | |
WO2012091440A3 (en) | Composition for improvement, treatment and prevention of gastrointestinal motility disorders | |
WO2012070835A3 (en) | Cosmetic composition containing gulfweed extract, sea staghorn extract, and brown seaweed extract | |
AU2010283453A8 (en) | Combination of proanthocyanidins such as Pycnogenol or grape seeds and Centella asiatica for the treatment of cardiovascular disorders such as atherosclerosis | |
WO2007083006A3 (en) | Use of an unsaponifiable extract of plant pulp in the treatment of skin ageing | |
WO2009031153A3 (en) | Pomegranate-derived products for the treatment of skin sores and lesions | |
WO2009047443A3 (en) | Cosmetic composition for improving skin condition | |
WO2012033329A3 (en) | Composition containing oenanthe javanica extract as an active ingredient for preventing or treating learning disabilities or memory disorders, and method for preparing same | |
WO2013025073A3 (en) | Composition for preventing or treating diabetes complications containing quamoclit pennata extract | |
WO2011014520A3 (en) | Compounds and compositions as modulators of gpr119 activity | |
WO2011055931A3 (en) | Composition for preventing or treating diseases caused by influenza viruses | |
WO2016190566A3 (en) | Pharmaceutical composition or functional health food for preventing and treating metabolic diseases, containing water extract of pleurotus eryngii var. ferulae (pf.) as active ingredient | |
WO2011118957A3 (en) | Composition for treating inflammatory, allergic or asthma diseases, containing paprika extracts | |
WO2012019435A3 (en) | Composition for treating neurodegenerative disease or neuropathological condition | |
WO2012127287A3 (en) | Compositions and methods for treating multi-drug resistant malaria | |
WO2011052935A3 (en) | Composition for lowering blood sugar, comprising extract of smilax chine l., momordica charantia and cordyceps militaris as active ingredient | |
WO2010134769A3 (en) | Composition for preventing or treating irritable bowel syndrome |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 201180043211.8 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 11823762 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 11823762 Country of ref document: EP Kind code of ref document: A2 |